
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) Receives Regulatory Approval For COVID-19 Vaccine in Younger Teenagers
Pfizer Inc (NYSE: PFE) and BioNTech SE received full regulatory authorization for their COVID-19 Vaccine for adolescents between 12 and 15 years in the US,












